MEDICINA
Departamento
Charité
Berlín, AlemaniaPublicaciones en colaboración con investigadores/as de Charité (40)
2024
-
Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report
International Journal of Cardiology, Vol. 395
2023
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
2021
-
A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome
Nature Communications, Vol. 12, Núm. 1
-
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases
Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085
-
Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature
Scientific Reports, Vol. 11, Núm. 1
-
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
Journal of the American College of Cardiology, Vol. 78, Núm. 5, pp. 421-433
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases
Scientific Reports, Vol. 10, Núm. 1
-
Standardization procedure for flow cytometry data harmonization in prospective multicenter studies
Scientific Reports, Vol. 10, Núm. 1
2019
-
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course
Journal of Clinical Medicine, Vol. 8, Núm. 11
-
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397
2017
-
Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 8, pp. 2359-2367
2016
-
Influence of TYK2 in systemic sclerosis susceptibility: A new locus in the IL-12 pathway
Annals of the Rheumatic Diseases, Vol. 75, Núm. 8, pp. 1521-1526
-
Off-label use of rituximab for systemic lupus erythematosus in Europe
Lupus Science and Medicine, Vol. 3, Núm. 1
2015
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
-
Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus
Arthritis and Rheumatology
2013
-
A systemic sclerosis and systemic lupus erythematosus pan-meta-GWAS reveals new shared susceptibility loci
Human Molecular Genetics, Vol. 22, Núm. 19, pp. 4021-4029
-
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry
European Journal of Heart Failure, Vol. 15, Núm. 10, pp. 1173-1184